Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;14(1):53-58.
doi: 10.26574/maedica.2019.14.1.53.

Short Update on C-Peptide and its Clinical Value

[Article in Modern Greek (1453-)]
Affiliations

Short Update on C-Peptide and its Clinical Value

[Article in Modern Greek (1453-)]
Carmen Novac et al. Maedica (Bucur). 2019 Mar.

Abstract

C-Peptide (“connecting” peptide – molecular formula C112H179N35O46) is a peptide made of 31 aminoacids, making the bond between A and B chains of insulin from the pro-insulin molecule. Pro-insulin is the precursor of the insulin that is synthesized in the beta-pancreatic cells. After its discovery in 1967 by Steiner et al, together with the discovery of insulin biosynthesis, C-peptide seemed to bring new benefits, having similar effects as those of insulin. Unfortunately, the subsequent studies have classified C-peptide as a biologically inactive peptide. After the ‘90s, however, both studies on animals and those on human subjects with type 1 diabetes where C-peptide had been administered showed that it played important biological parts in improving kidney function and nerve conduction velocity, as well as in increasing blood flow in muscles, skin, kidneys, thus being seen as a possible treatment for chronic complications of type 1 diabetes. Although for a long time C-peptide has been considered to be an inert biological product, recent research has emphasized its active biological function. C-peptide bonds to the membrane of certain types of cells (neuronal, endothelial, renal tubular cells, fibroblasts) through a surface receptor coupled with a G protein, and it determines multiple effects at the cellular level: it improves the quality of red cells, generating a better oxygenation of tissues; it has a vasodilator effect for muscles, skin, kidneys; it generates blood flow increase in skeletal muscles and at the skin level; it decreases glomerular hyper-filtering; it reduces albumin urinary excretion; it improves the function and structure of nerves in patients with type 1 diabetes and C-peptide deficiency, but not in healthy subjects. Therefore, C-peptide could have a therapeutic potential in preventing some of the late complications of diabetes mellitus.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Normal values of basal C-peptide in children (18)
TABLE 1.
TABLE 1.
Normal values of basal C-peptide in children (18)
TABLE 2.
TABLE 2.
Normal values of C-peptide in adults (18)

References

    1. Rhodes CJ, Shoelson S, Halban PA. Insulin Biosynthesis, Processing, and Chemistry, in: Joslin’s Diabetes Mellitus, 14th edition. 2005.
    1. Steiner DF, Cunningham D, Spigelman L, Aten B. Insulin biosynthesis:evidence for a precursor. Science. 1967;157:697–700. - PubMed
    1. Luppi P, Cifarelli V, Wahren J. C-peptide and long-term complications of diabetes. Pediatr Diabetes. 2011;12:276–292. - PubMed
    1. Sima AA, Zhang W, Muzik O, et al. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-peptide. Rev Diabet Stud. 2009;6:211–222. - PMC - PubMed
    1. Wahren J, Ekberg K, Jörnvall H. C-peptide is a bioactive peptide. Diabetologia. 2007;50:503–509. - PubMed

LinkOut - more resources